The effects of indirubin-3′-monoxime, a novel AHR ligand, on stress and toxicity-related gene/protein expression in human U937 cells undergoing differentiation and activation

Journal of Immunotoxicology

Volumn 3, Issue 1, 2006, Pages 1-10

  Springs, Alison E B ^a   Rice, Charles D ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

Aryl hydrocarbon receptor; Indirubin 3 monoxime; Macroarray; U937 cells

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BETA ACTIN; CATALASE; CYCLOOXYGENASE 2; CYTOCHROME P450 1A1; GLUTAMATE DEHYDROGENASE [NAD(P)]; GLUTATHIONE PEROXIDASE; HEME OXYGENASE 1; INDIRUBIN; INDIRUBIN 3' MONOXIME; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL STRAIN U937; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; GENOTOXICITY; HISTIOCYTIC LYMPHOMA; HUMAN; HUMAN CELL; IMMUNE SYSTEM; LYMPHOMA CELL; MODEL; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDITY;

EID: 33644775541     PISSN: 1547691X     EISSN: 1547691X     Source Type: Journal    
DOI: 10.1080/15476910500468627     Document Type: Article

References (45)

1. Adachi, J., Mori, Y., Matsui, S., Takigami, H., Fujino, J., Kitagawa, H., Miller, C. A., Kato, T., Saeki, K., and Matsuda, T. 2001. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 276:31475-31478.
2. Barile, F. A., Arjun, S., and Hopkinson, D. 1993. In vitro cytotoxicity testing: Biological and statistical significance. Toxicol. In Vitro 7:111-116.
3. Bhushan, B., Samanta, S. K., and Jain, R. K. 2000. Indigo production by naphthalene-degrading bacteria. Lett. Appl. Microbiol. 31:5-9.
4. Boise, L. H., Gonzalez-Garcia, M., Postema, C. F., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. 1993. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
5. Caron, E., Liautard, J. P., and Kohler, S. 1994. Differentiated U937 cells exhibit increased bactericidal activity upon LPS activation and discriminate between virulent and avirulent Listeria and Brucella species. J. Leukocyte Biol. 56:174-181.
6. Cooksey, C. J. 2001. Tyrian purple: 6,6′-Dibromoindigo and related compounds. Molecules 6, 736-769.
7. Coqueret, O. 2003. New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends Cell Biol. 13:65-70.
8. Crawford, R. B., Holsapple, M. P., and Kaminski, N. E. 1997. Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand. Mol. Pharmacol. 52:921-927.
9. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditits elegans cell death protein Ced-3 and mammalian interleukin-1 β-converting enzyme. J. Biol. Chem. 269:30761-30764.
10. Grohmann, U., Fallarino, F., and Puccetti, P. 2003. Tolerance, DCs and tryptophan: Much ado about IDO. Trends Immunol. 34:242-248.
11. Gu, Y., Hogenesch, J. B., and Bradfield, C. A., 2000. The PAS Superfamily: Sensors of environmental and developmental signals. Ann. Rev. Pharmacol. Toxicol. 40:519-561.
12. Guengerich, F. P., Martin, M. V., McCormick, W. A., Nguyen, L. P., Glover, E., and Bradfield, C. A. 2004. Aryl hydrocarbon receptor response to indigoids in vitro and in vivo. Arch. Biochem. Biophys. 423:309-316.
13. Hahn, M. E. 1998. The aryl hydrocarbon receptor: A comparative perspective. Comp. Biochem. Physiol. Part C. 121:23-53.
14. Hayashi, S., Okabe-Kado, J., Honma, Y., and Kawajiri, K. 1995. Expression of Ah receptor (TCDD receptor) during human monocytic differentiation. Carcinogenesis 16:1403-1409.
15. Heath-Pagliuso, S., Rogers, W. J., Tullis, K., Seidel, S. D., Cenijn, P. H., Brouwer, A., and Denison, M. S. 1998. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 37:11508-11515.
16. Helferich, W. G., and Denison, M. S. 1991. Ultraviolet photoproducts of tryptophan can act as dioxin agonists. Mol. Pharmacol. 40:674-678.
17. Hennig, B l., Meerarani, P., Slim, R., Toberk, M., Daugherty, A., Silverstone, A. E., and Robertson, L. W. 2002. Proinflammatory properties of coplanar PCBs: In vitro and in vivo evidence. Toxicol. Appl. Pharmacol. 181:174-183.
18. Hewison, M., Brennan, A., Singh-Ranger, R., Walters, J. C., Katz, D. R., and O'Riordan, J. L. 1992. The comparative role of 1,25-dihydroxycholecalciferol and phorbol esters in the differentiation of the U937 cell line. Immunology 77:304-311.
19. Hoessel, R., Leclerc, S., Endicott, J. A., Nobel, M. E. M., Lawrie, A., Tunnah, P., Leost, M., Damiens, E., Marie, D., Marko, D., Niederberger, E., Tang, W., Eisenbrand, G., and Meijer, L. 1999. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol. 1:60-67.
20. Hoffman, E. C., Reyes, H., Chu, F. F., Sander, F., Conley, L. H., Brooks B. A., and Hankinson, O. 1991. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252:954-958.
21. Holsapple, M. P., Karras, J. G., Ledbetter, J. A., Schieven, G. L., Burchiel, S. W., Davila, D. R., Schatz, A. R., and Kaminski, N. E. 1996. Molecular mechanisms of toxicant-induced immunosuppression: Role of second messengers. Ann. Rev. Pharmacol. Toxicol. 36:131-159.
22. Husoy, T., Syversen, T., and Jenssen, J. 1993. Comparisions of four in vitro cytotoxicity tests: MTT assay, NR assay, uridine incorporation and protein measurements. Toxicol. In Vitro 7:149-154.
23. Kafafi, S. A., Afeefy, H. Y., Ali, A. H., Said, H. K., and Kafafi, G. 1993. Binding of polychlorinated biphenyls to the aryl hydrocarbon receptor. Environ. Health Perspect. 101:422-428.
24. Kergosien D. H., and Rice, C. D. 1998. Macrophage secretory function is enhanced by low levels of tributyltin-oxide (TBTO), but not tributyltin-chloride (TBTCl) Arch. Environ. Contam. Toxicol. 34:223-228.
25. Kitaya, K., Nakayama, T., Okubo, T., Kuroboshi, H., Fushiki, S., and Honjo, H. 2003. Expression of macrophage inflammatory protein-1β in human endometrium: Its role in endometrial recruitment of natural killer cells. J. Clin. Endocrinol. Metab. 88:1809-1814.
26. Komura, K., Hayashi, S., Makino, I., Poellinger, L., and Tanaka, H. 2001. Aryl hydrocarbon receptor/dioxin receptor in human monocytes and macrophages. Mol. Cell Biochem. 226:107-118.
27. Kunikata, T., Tatefuji, T., Aga, H., Iwaki, K., Ikeda, M., and Kurimoto, M. 2000. Indirubin inhibits inflammatory reactions in delayed-type hypersensitivity. Eur. J. Pharmacol. 410:93-100.
28. Leclerc, S., Gamier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y., Mandelkow, E., Eisenbrand, G., and Meijer, L. 2001. Indirubins inhibit glycogen synthase kinase-3/3 and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. J. Biol. Chem. 276:251-260.
29. Ligam, P., Manuelpillai, U., Wallace, E.M., and Walker, D. 2004. Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in human placenta and decidua: Implications for role of the kynurenine pathway in pregnancy 2005. Placenta. 26:498-504.
30. Littman, B. H., Hall, R. E., and Muchmore, A. V. 1983. Lymphokine and phorbol (PMA) regulation of complemnet (C2) synthesis using U937. Cell Immunol. 76:189-195.
31. Marko, D., Schatzle, S., Friedel, A., Genzlinger, A., Zankl, H., Meijer, L., and Eisenbrand, G. 2001. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br. J. Cancer. 84:283-289.
32. Meijer, L., Skaltsounis, A., Magiatis, P., Polychronopoulos, P., Knockaert, M., Leost, M., Ryan, X. P., Vonica, C. A., Brivanlou, A., Dajani, R., Crovace, C., Tarricone, C., Musacchio, A., Roe, S. M., Pearl, L., and Greengard, P. 2003. GSK-3-selective inhibitors derived from tyrian purple indirubins. Chem. Biol. 10:1255-1266.
33. Mellor, A. L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D., and Munn, D. H. 2001. Prevention of T-cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat. Immunol. 2:64-68.
34. Mellor, A. L., Chandler, P., Baban, B., Hansen, A. M., Marshall, B., Pihkala, J., Waldmann, H., Cobbold, S., Adams, E., and Munn, D. H. 2004. Specific subsets of murine dendritic cells acquire potent T-cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int. Immunol. 16:1391-1401.
35. Miller, C. A. 1999. A human aryl hydrocarbon receptor signalling pathway constructed in yeast displays additive responses to ligand mixtures. Toxicol. Appl. Pharmacol. 160:297-303.
36. Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D., B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., Slingluff, C. L., and Mellor, A. L. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297:1867-1870.
37. Nebert, D. W., and Dieter, M. Z. 2000. The evolution of drug metabolism. Pharmacology 3:124-135.
38. Nilsson, K., Forsbeck, K., Gidlund, M., Sundstrom, C., Totterman, T., Sallstrom, J., and Venge, P. 1981. Surface characteristics of the U-937 human histiocytic lymphoma cell line: Specific changes during inducible morphologic and functional differentiation in vitro. Haematol. Blood Transfus. 26:215-221.
39. Perdew, G. H., and Babbs, C. F. 1991. Production of Ah receptor ligands in rat fecal suspensions containing tryptophan or indole-3-carbinol. Nutr. Cancer 16:209-218.
40. Schnitzer, S.E., Schmid, T., Zhou, J., Eisenrand, G., and Brune, B. 2005. Inhibition of GSK3 by indirubin restores HIF-α accumulation under prolonged periods of hypoxia/anoxia. FEBS Lett. 579:529-533.
41. Sherry, B., Tekamp-Olson, P., Gallegos, C., Bauer, D., Davatelis, G., Wolpe, S. I., Masiarz, F., Coit, D., and Cerami, A. 1988. Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1 β. J. Exp. Med. 168:2251-2259.
42. Song, J., Clagett-Dame, M., Peterson, R. E., Hahn, M. E., Westler, W. M., Sicinski, R. R., and DeLuca, H. F. 2002. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc. Natl. Acad. Sci., USA 99:14694-14699.
43. Spink, B. C., Hussain, M. M., Katz, B. H., Eisele, L., and Spink, D. C. 2003. Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. Biochem. Pharmacol. 66:2313-2321.
44. Sugihara, K., Kitamura, S., Yamada, T., Okayama, T., Ohta, S., Yamashita, K., Yasuda, M., Fuji-Kuriyama, Y., Saeki, K., Matsui, S., and Matsuda, T. 2004. Aryl hydrocarbon receptor-mediated induction of microsomal drug-metabolizing enzyme activity by indirubin and indigo. Biochem. Biophys. Res. Commun. 318:571-578.
45. Sundstrom, C., and Nilsson, K. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. 17:565-577.